Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership349,179 shares
Latest Disclosed Value $ 46,000,808
Goldman Sachs Group Inc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 349,179 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $46,000,808 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 364,532 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -4.21% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 13,700 of underlying shares valued at $1,804,838 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 349,179 -15,353 -4.21 46,001 -11.03 0.0012
2026-02-10 2025-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 364,532 -245,081 -40.20 51,702 -39.59 0.0064
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 609,613 -76,252 -11.12 85,577 -0.73 0.0105
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 685,865 -51,572 -6.99 86,206 5.70 0.0117
2025-06-27 2025-03-31 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 737,437 -246,362 -25.04 81,560 -39.26 0.0132
2025-05-16 2025-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 737,437 -246,362 81,560 0.0132
2025-05-09 2025-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 737,437 -246,362 81,560 0.0025
2025-02-11 2024-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 983,799 -33,355 -3.28 134,289 14.58 0.0212
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,017,154 -115,435 -10.19 117,197 -24.84 0.0189
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,132,589 356,862 46.00 155,924 45.74 0.0264
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 775,727 84,095 12.16 106,988 17.40 0.0190
2024-05-14 2023-12-31 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 691,632 -95,323 -12.11 91,129 2.93 0.0168
2024-03-01 2023-12-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 691,632 -95,323 91,129 0.0043
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 691,632 -95,323 91,129 0.0164
2024-05-15 2023-09-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 786,955 -37,682 -4.57 88,532 13.85 0.0188
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 786,955 -37,682 88,532 0.0178
2024-05-14 2023-06-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 824,637 -145,163 -14.97 77,763 -20.78 0.0167
2023-08-15 2023-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 824,637 -145,163 77,763 0.0157
2024-05-14 2023-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 969,800 -359,922 -27.07 98,163 -38.19 0.0226
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 969,800 -359,922 98,163 0.0210
2024-05-14 2022-12-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,329,722 127,932 10.65 158,822 124,955.91 0.0389
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,329,722 127,932 158,822 0.0355
2024-05-14 2022-09-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,201,790 -53,033 -4.23 128 4.10 0.0323
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,201,790 -53,033 127,642 0.0295
2024-05-14 2022-06-30 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 1,254,823 -241,629 -16.15 122 -99.91 0.0306
2022-08-18 2022-06-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,254,823 -241,629 122,320 0.0276
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,254,823 -241,629 122,320 0.0276
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,496,452 -28,063 -1.84 140,292 8.05 0.0295
2022-02-17 2021-12-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,524,515 81,017 5.61 129,843 -6.21 0.0258
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,524,515 81,017 129,843 0.0075
2022-01-20 2021-09-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,443,498 20,210 1.42 138,446 -0.05 0.0294
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,443,498 20,210 138,446 0.0293
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,423,288 15,814 1.12 138,514 1.20 0.0310
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,407,474 189,709 15.58 136,877 17.27 0.0345
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,217,765 328,594 36.96 116,723 36.51 0.0300
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 889,171 -55,498 -5.87 85,503 -25.81 0.0243
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 944,669 42,587 4.72 115,250 47.61 0.0350
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 902,082 242,342 36.73 78,076 10.10 0.0275
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 659,740 -8,347 -1.25 70,915 17.80 0.0181
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 668,087 95,698 16.72 60,201 24.57 0.0174
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 572,389 37,857 7.08 48,327 2.62 0.0139
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 534,532 -43,115 -7.46 47,093 14.16 0.0142
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 577,647 -733,011 -55.93 41,250 -74.40 0.0131
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,310,658 -128,782 -8.95 161,146 13.96 0.0416
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,439,440 -341,934 -19.19 141,411 -4.28 0.0383
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,781,374 -351,821 -16.49 147,729 -10.75 0.0378
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 2,133,195 -305,162 -12.52 165,515 10.77 0.0396
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 2,438,357 -235,860 -8.82 149,422 21.47 0.0366
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 2,674,217 930,268 53.34 123,014 62.90 0.0318
2017-05-18 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 1,743,949 997,434 133.61 75,513 161.38 0.0205
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 1,743,949 75,513
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 746,515 24,619 3.41 28,890 -20.97 0.0082
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 721,896 81,257 12.68 36,557 25.55 0.0111
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 640,639 -142,600 -18.21 29,117 -6.00 0.0095
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 783,239 574,102 274.51 30,977 161.83 0.0102
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 209,137 -112,837 -35.05 11,831 -7.66 0.0037
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 321,974 87,128 37.10 12,812 14.22 0.0043
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 234,846 -333,762 -58.70 11,217 -50.32 0.0035
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 568,608 154,995 37.47 22,579 144.36 0.0073
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 413,613 -203,819 -33.01 9,240 -4.50 0.0029
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 617,432 -4,647 -0.75 9,675 4.83 0.0031
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 622,079 -119,491 -16.11 9,229 -22.70 0.0029
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 741,570 321,720 76.63 11,939 204.49 0.0039
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 419,850 -120,142 -22.25 3,921 -35.86 0.0013
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 539,992 187,314 53.11 6,113 29.57 0.0023
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 352,678 319,052 948.83 4,718 1,772.22 0.0018
2013-06-14 2012-12-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 33,626 -95,430 -73.94 252 -75.53 0.0001
2013-06-14 2012-09-30 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 129,056 -357,167 -73.46 1,030 -73.17 0.0004
2013-06-14 2012-06-30 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 486,223 435,426 857.19 3,839 847.90 0.0017
2013-06-14 2012-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 50,797 50,797 405 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 3,200 402 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A NEUROCRINE BIOSCIENCES CMN Call 30,000 2,555 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 30,000 2,555 n/a n/a n/a
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 32,700 2,830 n/a n/a n/a
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 92,500 5,668 n/a n/a n/a
2017-05-18 2017-03-31 13F/A NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 25,000 -87.69 968 -89.51 n/a n/a n/a
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 203,100 416.79 9,231 494.02 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 39,300 -56.53 1,554 -69.61 n/a n/a n/a
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 90,400 -70.40 5,114 -57.92 n/a n/a n/a
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 305,400 524.54 12,152 420.43 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 48,900 -0.20 2,335 19.99 n/a n/a n/a
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 49,000 1,946 n/a n/a n/a
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 379,500 5,947 n/a n/a n/a
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 94,900 1,528 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 13,700 448.00 1,805 409.60 n/a n/a n/a
2026-02-10 2025-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 2,500 0.00 355 1.14 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES CMN Put 2,500 -77.88 351 -75.35 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 11,300 1,420 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A NEUROCRINE BIOSCIENCES CMN Put 30,000 2,555 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 30,000 2,555 n/a n/a n/a
2022-01-20 2021-09-30 13F/A NEUROCRINE BIOSCIENCES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES CMN Put 0 0 n/a n/a n/a
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 140,000 0.00 13,625 0.07 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 140,000 -9.79 13,615 -8.48 n/a n/a n/a
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 155,200 137.67 14,876 136.92 n/a n/a n/a
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES CMN Put 65,300 30.34 6,279 2.73 n/a n/a n/a
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 50,100 -16.64 6,112 17.49 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 60,100 20.20 5,202 -3.20 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 50,000 5,374 n/a n/a n/a
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 39,300 -21.56 1,554 -45.17 n/a n/a n/a
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 50,100 -41.88 2,834 -17.38 n/a n/a n/a
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES CMN Put 86,200 76.28 3,430 46.90 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 48,900 -0.20 2,335 19.99 n/a n/a n/a
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 49,000 1,946 n/a n/a n/a
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES CMN Put 131,700 42.53 2,064 50.55 n/a n/a n/a
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES CMN Put 92,400 -34.19 1,371 -39.34 n/a n/a n/a
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES CMN Put 140,400 2,260 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.